PubRank

M R Baer

Author PubWeight™ 49.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998 2.33
2 Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 1996 1.99
3 Rheumatoid arthritis and pure red cell aplasia. Ann Intern Med 1984 1.59
4 A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplant 2005 1.56
5 Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. Leuk Res 2001 1.54
6 Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res 1994 1.54
7 Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer 1998 1.52
8 Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 1996 1.49
9 Multidrug resistance in acute myeloid leukemia. J Natl Cancer Inst 1991 1.45
10 Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia 2010 1.41
11 Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood 2001 1.38
12 Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol 1997 1.36
13 Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999 1.36
14 Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant 2003 1.32
15 Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res 2007 1.28
16 Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene 2012 1.05
17 Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998 1.02
18 Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome. Cancer 1985 0.98
19 A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia. Leukemia 2013 0.95
20 Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res 1998 0.94
21 NCCN Practice Guidelines for Acute Myelogenous Leukemia. Oncology (Williston Park) 2000 0.91
22 The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia. Leukemia 2012 0.89
23 Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function. Leukemia 2004 0.89
24 Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia. Leukemia 2010 0.89
25 A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts. Cancer Res 2001 0.88
26 Malignant histiocytoses developing in patients with B-cell lymphomas. Report of two cases. Cancer 1986 0.88
27 Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritis. Leuk Lymphoma 2001 0.87
28 Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study. Am J Hematol 1995 0.86
29 Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 2007 0.86
30 HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia 2001 0.86
31 Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 2003 0.84
32 Palmar-plantar erythrodysesthesia and cytarabine. Ann Intern Med 1985 0.84
33 HLA-DR antigen-negative acute myeloid leukemia. Leukemia 2003 0.84
34 Granulomatous amebic encephalitis: an under-recognized cause of infectious mortality after hematopoietic stem cell transplantation. Transpl Infect Dis 2011 0.83
35 Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blasts. Leuk Lymphoma 1998 0.79
36 Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature. Leuk Lymphoma 2005 0.78
37 Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia. Blood 2001 0.78
38 Malignant histiocytosis occurring with acute myelogenous leukemia in a patient with longstanding polycythemia vera. Cancer 1987 0.78
39 Translocation (3;21) characterizes crises in myeloid stem cell disorders. Cancer Genet Cytogenet 1991 0.78
40 A compact strip-line pulsed power generator for isentropic compression experiments. Rev Sci Instrum 2008 0.78
41 Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin. Bone Marrow Transplant 2001 0.78
42 Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia. Leukemia 2008 0.77
43 Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors. Biol Blood Marrow Transplant 1999 0.77
44 Enhanced expression of the granulocyte-macrophage colony stimulating factor gene in acute myelocytic leukemia cells following in vitro blast cell enrichment. Blood 1988 0.77
45 Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. J Clin Oncol 1997 0.77
46 A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia. Cancer Chemother Pharmacol 1999 0.76
47 Symptomatic response to imatinib mesylate in cutaneous mastocytosis associated with chronic myelomonocytic leukemia. Curr Oncol 2013 0.75
48 Uptake and intracellular distribution of doxorubicin metabolites in B-lymphocytes of chronic lymphocytic leukemia. Cancer Res 1988 0.75
49 Deletion of chromosome 22 without bcr rearrangement and without juxtaposition of c-abl in a case of acute myeloid leukemia. Cancer Genet Cytogenet 1993 0.75
50 Acute promyelocytic leukemia: an update. Ann Oncol 1991 0.75
51 Uncommon patterns of presentation of leukemia. Hematol Oncol 1999 0.75
52 P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults. Ann Hematol 2004 0.75
53 Variable differentiation patterns of acute myelogenous leukaemia blasts in liquid suspension cultures. Br J Haematol 1987 0.75
54 Involvement of bands 9q21-q22 in five cases of acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1989 0.75
55 An acquired Robertsonian translocation dic(14;14)(p11;p11) in a patient with a myelodysplastic syndrome following treatment of multiple myeloma. Cancer Genet Cytogenet 1988 0.75
56 Immunotherapy of acute myeloid leukemia. Curr Pharm Biotechnol 2001 0.75
57 Improved survival in adult acute lymphoblastic leukemia. Need for more effective CNS prophylaxis. Am J Clin Oncol 1985 0.75
58 Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen. Cancer Treat Rep 1986 0.75
59 High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis. Am J Hematol 2001 0.75
60 Clinical experience with amphotericin B in acute myelogenous leukemia. South Med J 1986 0.75
61 Normal full-term pregnancy in a patient with chronic myelogenous leukemia treated with alpha-interferon. Am J Hematol 1991 0.75
62 Deletion of the long arm of chromosome 5 (5q-) as a secondary event in the course of refractory anemia. Cancer Genet Cytogenet 1986 0.75
63 Translocation (2;7)(p13;q36) in a case of acute nonlymphocytic leukemia evolving from a myelodysplastic syndrome. Cancer Genet Cytogenet 1988 0.75
64 Translocation (1;6)(p12;p23) in ANLL. Cancer Genet Cytogenet 1990 0.75
65 Thrombopoietin receptor in acute myeloid leukemia. Leuk Res 1999 0.75
66 Trisomy/tetrasomy 13 in seven cases of acute leukemia. Leukemia 1990 0.75
67 Acute nonlymphocytic leukemia in a patient with a constitutional inv(4). Cancer Genet Cytogenet 1989 0.75